Genetic Predictors of Chemotherapy-Induced Peripheral Neuropathy from Paclitaxel, Carboplatin and Oxaliplatin: NCCTG/Alliance N08C1, N08CA and N08CB Study

Genetic Predictors of Chemotherapy-Induced Peripheral Neuropathy from Paclitaxel, Carboplatin and Oxaliplatin: NCCTG/Alliance N08C1, N08CA and N08CB Study

Chemotherapy-induced peripheral neuropathy (CIPN) is a common and potentially permanent adverse effect of chemotherapeutic agents including taxanes such as paclitaxel and platinum-based compounds such as oxaliplatin and carboplatin. Previous studies have suggested that genetics may impact the risk o...

Full description

Bibliographic Details
Main Authors: Araba A. Adjei, Camden L. Lopez, Daniel J. Schaid, Jeff A. Sloan, Jennifer G. Le-Rademacher, Charles L. Loprinzi, Aaron D. Norman, Janet E. Olson, Fergus J. Couch, Andreas S. Beutler, Celine M. Vachon, Kathryn J. Ruddy
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Cancers
Subjects:
chemotherapy-induced peripheral neuropathy
genome-wide associated study
toxicity
Online Access:https://www.mdpi.com/2072-6694/13/5/1084

Internet

https://www.mdpi.com/2072-6694/13/5/1084

Similar Items